OUR DOCTORS

Our vein specialists are not your average doctors.  They vein train and teach other doctors, medical students, physician assistants, and empower and educate patients everyday with knowledge and choices.  They lead clinical research studies and contribute to scientific journal and textbook publications.  Our recent research made the cover of the “Journal for Vascular Ultrasound” in March, 2018.  Our doctors continuously strive to elevate the standard in vein care- they are fellowship-trained, board certified in venous and lymphatic disease, and earned additional credentials in ultrasound interpretation to provide comprehensive vein care for all patients.

drlucas-out

Sarah Lucas MD, FACS, RPVI

Vascular Surgeon   Director, Non-invasive Vascular Laboratory

Dr. Sarah Lucas, MD, FACS, RPVI is a board-certified vascular surgeon who has chosen to focus her practice on the care of patients with venous and lymphatic disease. She is also a diplomate of the American Board of Venous and Lymphatic Medicine. She is a graduate of the Duke School of Medicine and the integrated vascular surgery residency of Georgetown University Hospital and Medstar Washington Hospital Center in Washington, DC. She returned to Duke as a faculty member following graduation.

She and her husband then relocated to Memphis, Tennessee for his pediatric surgery fellowship. During that time, she was on staff at the Memphis VA Medical Center, where she served as faculty for the vascular surgery fellowship of the University of Tennessee Health Sciences Center.

Dr. Lucas and her husband are delighted to have found their permanent home in San Diego, where he is a pediatric surgeon at the Naval Medical Center.

Dr. Lucas has authored numerous peer-reviewed publications and a book chapter in the field of vascular surgery. She is active in the Society for Vascular Surgery and a member of the Young Surgeons’ Committee. Dr. Lucas joined La Jolla Vein Care in 2018. In addition to her role at La Jolla Vein Care, she also manages patients with vascular wounds at the Scripps XIMED wound care clinic.

Dr. Lucas is a Fellow of the American College of Surgeons. Surgeons who become Fellows of the College have passed a comprehensive evaluation of their surgical training and skills; they also have demonstrated their commitment to high standards of ethical conduct.

Peer-Reviewed Journals:Dr. Sarah Lucas

Dr. Sarah Lucas, La Jolla Vein Care, Veinous insufficiency during pregnancy on KUSI

Armin Foghi, M.D., Ph.D.

Armin Foghi, M.D., Ph.D.

Vein Specialist, Invasive/non-invasive Cardiologist

Dr. Armin Foghi, MD PhD founded and was the medical director for Myo Vein Clinic in New Mexico since 2008. Myo clinic vein program has evolved and excelled to be considered the most advanced and respected vein program in the state of the New Mexico for the last five consecutive years.

Under Dr Foghi’s directorship, Myo Clinic was recognized nationally as the Center of Excellence for complete and comprehensive vein treatment as well as training center for physicians across USA. Dr Foghi has performed more than 10,000 vein procedures with 100% success rate. Dr Foghi has also been at the heart of the development of Myo Cardiovascular Clinic.

Previous Chief of Cardiology at Eastern New Mexico Medical Center and the founder of Myo Cardiovascular Center at Eastern New Mexico. He has been involved in state-of-the-art molecular cardiology research at University of New Mexico thanks to a PhD in molecular cell biology and biochemistry fields. He has been an active educator and lecturer for cardiovascular disease in various residency training and physician assistant programs. Dr Foghi has also kept the title, assistant Professor, at University of New Mexico Medical Center for the last decade.

Foghi A, Teerds KJ, van der Donk H, Moore NC, Dorrington J, Induction of apoptosis in    thecal/interstitial cells: action of transforming growth factor (TGF) a plus TGF b on Bcl2 and interleukin-1 beta-converting enzyme, J Endocrinol 1998 Jun; 157(3): 489-94.

Foghi A, Ravandi A, Teerds KJ, Van Der Donk H, Kuksis A, Dorrington J, Fas-induced apoptosis in rat thecal/interstitial cells signals through sphingomyelin-ceramide pathway, Endocrinology 1998 Apr; 139(4): 2041-7.

Foghi A, Teerds KJ, van der Donk H, Dorrington J, Induction of apoptosis in rat thecal/interstitial cells by transforming growth factor alpha plus transforming growth factor beta in vitro, Journal of Endocrinology 1997 Apr; 153(1): 169-78.

Ghahremani M, Foghi A, Dorrington JH, Etiology of ovarian cancer: a proposed mechanism, Med Hypotheses 1999 Jan; 52(1): 23-6.

Ghahremani M, Foghi A, Dorrington JH, Activation of Fas ligand/receptor system kills ovarian cancer cell lines by an apoptotic mechanism, Gynecol Oncol 1998 Aug; 70(2): 275-81.

A Foghi MD PhD, WK Laskey MD, A Jenkins MD, S Rohde, V Severns, C Wells RN, C. Mobarak PhD.Proteomic Analysis and Radiographic Contrast Solution In Coronary Angiography (submitted).

Armin Foghi, Katja Teerds, Hans van der Donk, Jennifer Dorrington, Apoptosis: Mechanism of cell death of thecal cells in atretic follicles. Society for the study of Reproduction (SSR). 28th annual meeting (Davis, CA, July 1995).

Armin Foghi, Katja Teerds, Hans van der Donk, Jennifer Dorrington, Apoptosis mechanism of cell death in rat thecal/interstitial in atretic follicles. The Clinical Research Society of Toronto (CRST), (Toronto, Canada, March 1995).

 Armin Foghi, Jennifer Dorrington, Transforming growth factor alpha (TGF a) plus Beta (TGF b) induces apoptosis through sphingomyelin-ceramide cycle, The Clinical Research Society of Toronto, Page 24, (Toronto, Canada, April 1996).

 Armin Foghi, Jennifer Dorrington, Induction of apoptosis by TGF a plus TGF b mediated by Bcl2 and ICE, The Clinical Research Society of Toronto, Page 24, (Toronto, Canada, April 1996).

 Armin Foghi, Jennifer Dorrington, Transforming growth factor alpha (TGF a) plus Beta (TGF b) induces apoptosis through sphingomyelin-ceramide cycle, Southern Ontario Reproductive Biology Meeting (SORB), Page 2, (Guelph, Ontario, Canada, May 1996).

 Armin Foghi, Jennifer Dorrington, Transforming growth factor alpha (TGF a) plus Beta (TGF b) induces apoptosis through sphingomyelin-ceramide cycle, 15th Annual Ottawa Reproductive Biology Workshop, Page 3, (Ottawa, Ontario, Canada, June 1996).

Armin Foghi, Jennifer Dorrington, Transforming growth factor alpha (TGF a) plus Beta (TGF b) induces apoptosis through sphingomyelin-ceramide cycle, XIth ovarian Workshop: Ovarian Cell Growth, Apoptosis and Cancer, Page 2, (London, Ontario, Canada, July 1996).

 Armin Foghi, Katja Teerds, Hans van der Donk, Jennifer Dorrington, Potential mechanism involved in elimination of thecal cells during atresia: Action of Transforming growth factor alpha (TGF a) plus Beta (TGF b) on Bcl2 and interleukin-1 beta-converting enzyme (ICE), Society for the study of Reproduction (SSR), 29th Annual Meeting, Page 96, (London, Ontario, Canada, July 1996).

 Armin Foghi, Katja Teerds, Hans van der Donk, Jennifer Dorrington Apoptotic induction by Transforming growth factor alpha (TGF a) plus Beta (TGF b) in thecal/interstitial cells is mediated through increase in oxidative stress, The Canadian Fertility and Andrology Society, 42nd Annual meeting (Alberta, BC, Canada, 1996).

Armin Foghi and Jennifer Dorrington, FAS mediated apoptosis in rat thecal/interstitial cells in vitro, 7th Annual Winternational Symposium on Apoptosis and DNA repair (Quebec City, Canada, 1997).

Armin Foghi and Jennifer Dorrington, FAS mediated apoptosis in rat thecal/interstitial cells in vitro and in vivo, The Keystone Symposia on Molecular and Cellular Biology (Colorado, USA, 1997).

Dr. Foghi is featured in new Video NBC 7 San /Diego

Dr. Foghi will work closely with Dr. Nisha Bunke, MD, FACPh, RPhS, founder of La Jolla Vein Care, to deliver patient treatment through a holistic lens. He is already driving an expansion of services, including the utilization of EKG tests to assess heart health; leveraging imaging modalities for a big-picture view of circulatory system health; and treating patients through minimally invasive procedures.

bunke_Lab_out

Nisha Bunke, MD FACPh, RPhS

Venous Disease Interventionalist, Vein Clinic Medical Director,

Dr. Nisha Bunke was the first physician in the United States to complete fellowship training supported by the American Vein and Lymphatic Society (formerly known as the American College of Phlebology) in 2008 and is a diplomate of the American Board of Venous and Lymphatic Medicine. Over the past decade, Dr. Bunke has dedicated her career to treating patients with venous and lymphatic conditions and advancing the field of vein care.

Being inspired by her mentor, world-renowned vascular surgeon, Dr. John Bergan, who emphasized that venous disease is a special condition that requires specialized care, she founded La Jolla Vein Care in 2010. Under her leadership, La Jolla Vein Care was awarded accreditation in Vein Clinic and Vascular Testing by the Intersocietal Accreditation Commission (IAC). La Jolla Vein Care is the first dedicated vein care facility in the region to earn this distinction.

Prior to turning her complete attention to La Jolla Vein Care, she has held appointments as a Volunteer Clinical Instructor of Surgery at the University of California San Diego (UCSD) School of Medicine, and Veteran’s (VA) Medical Center.  In addition to these duties, for five years, Dr. Bunke managed the vein clinics at the VA Medical Center La Jolla, providing vein care for our veterans.  She was also a physician at UCSD Healthcare System’s Department of Vascular Surgery, were she evaluated and treated patients with venous disease.

Dr. Bunke is a physician and scientist, actively leading clinical research studies.  In 2009, Dr. Bunke was awarded the Internationale Union of Phlebologie Research Fellowship and the Best Young Presenter Award in Monaco.  Collectively, Dr. Bunke and Dr. Bergan were awarded the 2008 JOBST Research Award for the Advancement of Phlebology for their research on Inflammatory Bio-Markers of Venous Insufficiency. Dr. Bunke also developed Recova, a post-surgery recovery cream.

Dr. Bunke has been named as a finalist by the San Diego Business Journal’s Women Who Mean Business Award and San Diego Magazine’s Woman of the Year award.  In 2018, she was named as the top 25  Women of the Year by the San Diego Business Journal.

Moreover, Dr. Bunke is a member of the Scripps Ximed Medical Group, The Clinical and Translational Research Institute (CTRI) of the University of California San Diego (UCSD), the American Medical Association (AMA), San Diego County Medical Society, Society for Vascular Medicine, American Vein and Lymphatic Society, American Venous Forum (AVF) and the Society for Vascular Ultrasound (SVU). Dr. Bunke has numerous publications in both scientific journals and medical textbooks.

Dr. Bunke is co-editor of the most widely used textbook for vascular physicians, “The Vein Book”

Books/ Book Chapters: Dr. Nisha Bunke

Bergan, JJ, Bunke, N. “Outcome Measures in Venous Disease.” In:  Fast Facts- Vascular and Endovascular Surgery Highlights 2008-09.  Davies, A., Mitchell, A. M. Health Press UK

Bergan, JJ. Bunke, N.  “Varicose Veins and Chronic Venous Insufficiency.” In: Total Endovascular Series Venous Diseases Contemporary Management.’ Lumsden, A, Davies, M.

Bergan, JJ, Bunke, N.  “Venous Disorders.”  In:  Educational Review Manual in General Surgery. 8th Edition. Castle Connolly Graduate Medical Publishing.

Bergan, JJ, Bunke, N. “Pathophysiology of Chronic Venous Disease.”  In:  The European Venous Course Book.

Bergan JJ, Bunke, N. “Endovenous Procedures in Venous Disease.”  In:  Peripheral Endovascular Interventions.  White, R, Fogarty, T.  3rd Ed.

Bergan, JJ, Pascarella, L, Bunke, N. “Venous Anatomy, Physiology and Pathophysiology.”  In: Treatment of Leg Veins, 2nd ed.  Alam, M., Silapunt, S. Martin Mellor Publishing Ltd. UK

Bergan, J. Lee, BB, Bunke N.  “Lymphatic Disease.”  In: Clinical Review of Vascular Surgery. Edited by Sapan Desai, MD, PhD and Cynthia Shortell, MD.

Bergan, J. and Bunke, N. General Considerations. In: Lymphedema: A Concise Compendium of Theory and Practice. Edited by Byung-Boong Lee, John Bergan, Stanley G. Rockson 2011.

Bergan, JJ, Bunke-Paquette, N, editors. The Vein Book, 2nd edition. Oxford University Press, New York, NY USA. 2014

Bunke-Paquette, N. “Complications of Liquid Sclerotherapy.” In: The Vein Book, 2nd ed. Bergan, JJ, Bunke-Paquette, N. Oxford University Press, New York, NY USA. 2014

Loerzel, N, Ratcliff V, Bunke-Paquette, N, et al. “Ultrasound Examination of the Patient with Primary Venous Insufficiency.” In: The Vein Book, 2nd ed. Bergan, JJ, Bunke-Paquette, N. Oxford University Press, New York, NY USA. 2014

Bunke-Paquette, N, Loerzel, N, Bergan, JJ. “Ultrasound-Guided Catheter and Foam Therapy for Venous Insufficiency.’ In: The Vein Book, 2nd ed. Bergan, JJ, Bunke- Paquette, N. Oxford University Press, New York, NY USA. 2014

Bergan, JJ, Pascarella, L, Bunke-Paquette, N. “Perforating Veins.” In: The Vein Book, 2nd ed. Bergan, JJ, Bunke-Paquette, N. Oxford University Press, New York, NY USA. 2014

Bunke-Paquette, N. Russell, T, Broder, K, Li, A. “Medical Management of the Venous Leg Ulcer.” In: The Vein Book, 2nd ed. Bergan, JJ, Bunke-Paquette, N. Oxford University Press, New York, NY USA. 2014

Peer-Reviewed Journals

Bunke N, Brown K, Bergan J. Foam sclerotherapy: techniques and uses. Perspect Vasc Surg Endovasc Ther. 2009 Jun;21(2):91-3

Bunke N, Brown K, Bergan J. Phlebolymphemeda: usually unrecognized, often poorly treated. Perspect Vasc Surg Endovasc Ther. 2009 Jun;21(2):65

B.B. Lee, M. Andrade, P.L. Antignani,F. Boccardo, N. Bunke, et. al. Guidelines: Diagnosis and treatment of primary lymphedema consensus document of the international union of phlebology (IUP)-2013. International Angiology. 2013 Dec: (32): 541-574

Expert Healthcare

Our clinical staff consists of Registered Vascular Technologists (RVTs), Nurse Practitioners and Medical Assistants and ancillary staff who have several years of experience in vein care. Most of our staff have helped patients at La Jolla Vein Care for 5+ years.  We also have administrative staff with expertise in insurance preauthorizations, and in combination with our doctors, will fight for patients to get the treatment they need.

Because of our staff’s extensive experience in vein care, they are knowledgeable about vein conditions and treatment and are happy to answer questions any time.

La Jolla Vein Care Health Values

OUR MISSION IS TO PROVIDE OUR EXPERTISE AND SPECIALIZED TRAINING TO IMPROVE YOUR VASCULAR HEALTHIN A ONE-STOP CONVENIENT SETTING.  OUR COMPREHENSIVE VEIN CARE AND VASCULAR IMAGING CENTER HELP PATIENTS TAKE CONTROL OF THEIR VASCULAR HEALTH.

Icon11

OUR PATIENTS SAY

Make An Appointment

To make an appointment or to inquire about how we can help you understand your vein treatment options
Use chat or call 858-434-5998